Table 1.

Characteristics of included studies: participants

Source	Sample Size, No.	Age, Mean (SD), y	Sex (M/F)	DD, Mean (SD), y	H and Y Stage
Siebner et al,42 2000	10	57 (11)	7/3	6 (3)	1–2
Boylan et al,35 2001	8	63.5a	6/4a	8.6a	2–3
Shimamoto et al,28 2001	18	65 (7)	12/6	7 (5)	1.5–4
Khedr et al,24 2003	36b	58 (9)	24/12	3 (2)	2–3
Lefaucheur et al,39 2004	12	64 (9)	7/5	11 (5)	2.5–4
Khedr et al,33 2006	20	60 (10)	NA	4 (2)	3–5
Lomarev et al,25 2006	16	65 (10)	14/2	12 (5)	2–4
Brusa et al,36 2006	10	61 (8)	6/4	16 (5)	NA
del Olmo et al,31 2007	13	62 (5)	6/7	8 (5)	1–3
Hamada et al,34 2008	98	66 (9)	54/44	8 (5)	2–4
Sedlácková et al,41 2009	9	64 (7)a	9/1a	8 (7)a	NA
Filipović et al,37,38 2010, 2009	10	65 (10)	5/5	16 (6)	2–4
Pal et al,27 2010	22	69 (8)	11/11	6c	NA
Arias et al,23 2010	18	66 (9)	9/9	7 (3)	2–4
González-García et al,29 2011	17	65 (5)	11/6	NA	2–3
Benninger et al,32 2012	26	64 (9)	20/6	9 (5)	2–4
Maruo et al,26 2013	21	63 (11)	11/10	12 (6)	2–4
Shirota et al,30 2013	102d	67 (8)d	43/59d	5 (6)d	2–4d
Nardone et al,40 2014	4	66 (4)	3/1	10 (5)	2–4

Abbreviations: DD, disease duration H and A, Hoehn and Yahr; NA, not available.

^aData from enrolled participants.

^bParticipants who completed the repetitive transcranial magnetic stimulation sessions and the evaluation 1 hour after the session.

^cMedian disease duration.

^dData analyzed.